CERAMENT G as Part of the Surgical Treatment of Osteomyelitis in a Single-Stage Procedure

RecruitingOBSERVATIONAL
Enrollment

128

Participants

Timeline

Start Date

June 2, 2025

Primary Completion Date

October 31, 2031

Study Completion Date

October 31, 2032

Conditions
Osteomyelitis
Interventions
DEVICE

CERAMENT G

CERAMENT G is intended for use as a bone void filler as an adjunct to systemic antibiotic therapy and surgical debridement (standard treatment approach to a bone infection) as part of the surgical treatment of osteomyelitis. By eluting gentamicin, CERAMENT G can reduce the recurrence of chronic osteomyelitis from gentamicin-sensitive microorganisms in order to protect bone healing.

Trial Locations (1)

OX37HE

RECRUITING

Bone Infection Unit, Nuffield Orthopaedic Centtre, Oxford University Hospitals, MHS, Oxford

All Listed Sponsors
lead

BONESUPPORT AB

INDUSTRY

NCT06555848 - CERAMENT G as Part of the Surgical Treatment of Osteomyelitis in a Single-Stage Procedure | Biotech Hunter | Biotech Hunter